6 Results

People

  1. Dusza
    Dusza
  2. Ponce
    Ponce
  3. Markova
    Markova
  4. Perales
    Perales
  5. Prockop
    Prockop
  6. Chowdhury
    Chowdhury
  7. Lacouture
    Lacouture
  8. Pan
    Pan
  9. Nanda
    Nanda
  10. Afrin
    Afrin

Groups

  1. CTCR Scholars (6)
  2. Department of Medicine (6)
  3. Dermatology Service (6)
  4. Dermatology (6)
  5. Division of Subspecialty Medicine (6)
  6. MSK Grad Students (6)
  7. Master of Science in Clinical and Translational Cancer Research (6)
  8. Survivorship Research (6)
  9. Bone Marrow Transplant (5)
  10. Center for Hematologic Malignancies (5)
  1. "Division of Subspecialty Medicine "
  2. "Department of Medicine"
  3. "Survivorship Research"
  4. "Dermatology"
  5. "Stephen Dusza"
  6. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. CTCR Scholars (6)
  2. Department of Medicine (6)
  3. Dermatology (6)
  4. Dermatology Service (6)
  5. Division of Subspecialty Medicine (6)
  6. MSK Grad Students (6)

More Groups

People
  1. Stephen Dusza (6)
  2. Alina Markova (5)
  3. Doris Ponce (5)
  4. Mario Lacouture (4)
  5. Miguel-Angel Perales (4)
  6. Susan Prockop (4)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (1)
Publications
  1. Transplantation and Cellular Therapy (3)
  2. Blood (2)
  3. JAMA Dermatology (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Society of Hematology (2)
  3. American Medical Association (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial
    Meeting Abstract

    Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-time reflectance confocal microscopy of cutaneous graft-versus-host disease correlates with histopathology
    Journal Article

    Reingold, R. E.; Monnier, J.; Ardigò, M.; Stoll, J. R.; Pena, M. C.; Nanda, J. K.; Dusza, S. W.; Ruiz, J. D.; Flynn, L.; Afrin, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle- and comparator-controlled trial on safety and efficacy of a topical inhibitor of janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non- sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Pan, A.; Dusza, S.; Chowdhury, A.; Kukoyi, O.; Perales, M. A.; Lacouture, M.; Prockop, S.; Ponce, D. M.
    Blood (2021)

    Fulltext@MSK | Save
  • Performance of gene expression profile tests for prognosis in patients with localized cutaneous melanoma: A systematic review and meta-analysis
    Journal Article

    Marchetti, M. A.; Coit, D. G.; Dusza, S. W.; Yu, A.; McLean, L.; Hu, Y.; Nanda, J. K.; Matsoukas, K.; Mancebo, S. E.; Bartlett, E. K.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save